Valuation check: CGEN.TA's profit margin is 47.9%, above the Healthcare sector average of 17.63%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
Compugen (CGEN.TA) currently reports a profit margin of 47.9% as of September 2026. That compares with -400.1% in the prior-year period — up 112.0% year over year. That is above the Healthcare sector average of 17.63%. Use the charts on this page to explore Compugen's profit margin history and peer comparisons.
Compugen's profit margin increased from -400.1% to 47.9% — a 112.0% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Compugen's profit margin of 47.9% is higher than the Healthcare sector average of 17.63%. That is roughly 171.7% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Compugen's current 47.9% should be judged against Healthcare norms (sector average: 17.63%) and against CGEN.TA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 47.9%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 17.63%. From there, open related valuation or income-statement pages for Compugen, and consider following CGEN.TA for alerts when major investors trade the stock.